Close menu




August 23rd, 2022 | 12:23 CEST

When will these stocks be let off the leash? TUI, Barsele Minerals, ThyssenKrupp

  • Mining
  • Gold
  • Commodities
  • Travel
Photo credits: pixabay.com

All investors have probably experienced this phenomenon at some point or another: Operationally and fundamentally, companies are making really good progress. But the share price does not get going. We explain whether this is a warning signal and how investors can deal with such a situation. Today we look at the travel group TUI, which currently has little travel fever priced in, the steel group ThyssenKrupp, which is suffering from the energy crisis, and Barsele Minerals, where a valuable gold project is not yet putting its horsepower on the road.

time to read: 3 minutes | Author: Nico Popp
ISIN: TUI AG NA O.N. | DE000TUAG000 , BARSELE MINERALS | CA0688921083 , THYSSENKRUPP AG O.N. | DE0007500001

Table of contents:


    TUI: When will the "new broom" take effect?

    Travel group TUI should actually be feeling the boom these days: the summer travel season is reaching its peak, and by now, it should be clear whether the summer quarter was successful for TUI or not. After months of austerity and Corona measures, this summer was comparatively carefree. Many people flew on vacation. For the first time, far-away destinations were also in demand again. But the public debate about energy prices may have ultimately dissuaded many families from taking an expensive trip. So how was it then, the 2022 travel season?

    If you believe the DERTOUR Travel Barometer 2022, the sky is full of violins for the industry. On average, vacationers are spending more than 50% more on their hotel stay, choosing better hotel categories, staying longer, and opting for all-inclusive. However, this travel hype is not yet reflected in TUI's share price. Although the quarterly figures two weeks ago were still comparatively good, TUI is becoming restless. According to Wirtschaftswoche, CEO-designate Sebastian Ebel is already cracking down at TUI and wants to trim the tour operator to digital solutions and "more mass". The ticket sellers on the Internet are the role model. The share is currently trading at its low. The share also continues to appear oversold. According to the motto "a new broom sweeps clean", new CEO Ebel could quickly provide a liberation blow. The coming weeks will be exciting.

    Barsele Minerals: Enter cheaper than the pros

    Barsele Minerals has also been exciting for a long time. The Company, which holds the gold project of the same name in Sweden and operates it together with joint venture partner Agnico Eagle, speculated for months on a complete takeover of the project. The reasons: Commodity producer Agnico Eagle wanted to focus on North America, and Barsele believed it could quickly bring the project in Sweden into production or spruce it up for a buyer with greater funding. These plans have not yet come to fruition. Agnico Eagle remains on board with Barsele and continues to bear the exploration costs under the closed joint venture. In addition, funds from additional financing, which Barsele Minerals announced a few days ago, will soon be available.

    The Company initially planned to raise CAD 1 million in the form of 3.33 million shares at CAD 0.30. Each subscription unit would have included half a warrant in addition to 1 share. Each full warrant would have entitled the holder to purchase additional Barsele shares at CAD 0.45 within 24 months. After only a few days, Barsele Minerals doubled the total volume of the capital measure due to the high demand and confirmed that previous insiders would also participate in the measure. Barsele Minerals continues to expect to be able to prove a resource of up to 4 million ounces of gold with the necessary funds. Energy costs, which have risen sharply worldwide, should also continue to speak in favour of the Barsele project: In Sweden, electricity is unbeatably cheap thanks to nuclear and hydroelectric power. The share is currently trading in Germany below the level of the private placement. Anti-cyclical investors should keep Barsele Minerals on their radar.

    ThyssenKrupp: There is justified hope

    The analysts at Credit Suisse have also recently made a name for themselves as anti-cyclical investors - they issued a price target for steel group ThyssenKrupp that is three times higher than the current price. According to the Swiss, a share price of EUR 19.40 could be reached. The experts at Jefferies also still see the stock at EUR 13.80, well above the current level of EUR 5.71. ThyssenKrupp's stock is suffering from ongoing economic worries and fears of energy chaos in the winter. But the group with roots in the Ruhr region is better than its reputation: ThyssenKrupp has reinvented itself in recent years, selling some shareholdings and expanding others. Among other things, it wants to play a significant role in green hydrogen. It has also been able to increase both sales volumes and prices. There are signs of a turnaround at ThyssenKrupp - analysts also see a silver lining. However, this is still overshadowed by storm clouds. Those who are patient and courageous can profit in the long term.


    In the short term, the ThyssenKrupp share could well be dragged down again. TUI is also under pressure. In the case of stocks such as Barsele Minerals, the bare figures ensure that the downside risk should be limited - as recently as last year, Barsele CEO Gary Cope saw the value of the Barsele project at CAD 450 million. In the short term, however, fluctuations are also possible here. Investors who think long-term can benefit from such phases of uncertainty and, with a well-calibrated investment compass, take the right direction early on!


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.


    Der Autor

    Nico Popp

    Nico Popp

    At home in Southern Germany, the passionate stock exchange expert has been accompanying the capital markets for about twenty years. With a soft spot for smaller companies, he is constantly on the lookout for exciting investment stories.

    About the author



    Related comments:

    Commented by Jens Castner on October 30th, 2026 | 05:45 CET

    When the stock market gets it wrong: Schott Pharma clears its name; Lahontan Gold and Instone are the next candidates

    • Speciality glass
    • Gold
    • Real estate
    • Chemicals
    • Silver
    • Expropriation
    • Health
    • Berlin
    • Misvaluations
    • Mining
    • Schott Pharma
    • Instone Real Estate
    • Lahontan Gold

    Markets are quick to judge, and often paint companies with a broad brush. When one company runs into difficulties, its competitors immediately come under suspicion too. Schott Pharma has already been through this and dispelled the doubts with strong figures. Its share price is recovering. For Lahontan Gold and Instone Real Estate, the recovery has yet to come. The Canadian gold explorer is being punished alongside the major producers, while the property developer is being grouped with Berlin's residential landlords. In both cases, the facts tell a different story. The share price upside is considerable.

    Read

    Commented by Jens Castner on October 29th, 2026 | 05:40 CET

    A Breakout in the Making? Desert Gold Ventures and Oklo following in Moderna's footsteps

    • Cancer therapy
    • Gold
    • Nuclear power
    • Biotech
    • Commodities
    • Data centres
    • Desert Gold
    • Moderna
    • Oklo
    • Analysts
    • Price targets
    • Milestones
    • Quarterly reports
    • Precious metal

    Created and published on behalf of Desert Gold Ventures.

    Moderna has already made the big leap. Yet the best trial data in the company's history sent the shares tumbling, because the success was already priced in. The situation is different for two stocks that have also reached crucial milestones but still attract little attention on the stock market. Desert Gold Ventures is on the verge of its first gold production in Mali. Nuclear power specialist Oklo has commissioned its first reactor, but still needs a little more time before its commercial breakthrough. Analysts' price targets for both shares are several times their current prices.

    Read

    Commented by Carsten Mainitz on October 29th, 2026 | 05:31 CET

    Gold, Tickets, Turnarounds! Why Stock Pickers Should Take a Closer Look at DRC Gold, CTS Eventim and Mutares Now

    • Stock Picking
    • Alpha
    • Investments
    • Gold
    • Exploration
    • Acquisition
    • Activist Investor

    The stock market is no petting zoo. Investors seeking returns have to go hunting themselves. Stock picking is the art of finding tomorrow's winners before the rest of the market wakes up. Under the leadership of industry veteran Klaus Eckhof, DRC Gold is working to take a stake in a gold project in the northeast of the Democratic Republic of the Congo. This could take the company to a whole new level. CTS Eventim is attracting renewed attention thanks to an activist investor. This could boost the share price. Mutares has many irons in the fire. Who is ahead?

    Read